Evidence map›Paper›PMID 22721434›Full record

ArticleArthritis research & therapy2012

Hyaluronan injection in murine osteoarthritis prevents TGFbeta 1-induced synovial neovascularization and fibrosis and maintains articular cartilage integrity by a CD44-dependent mechanism.

Jun Li, Daniel J Gorski, Wendy Anemaet, Jennifer Velasco, Jun Takeuchi, John D Sandy, Anna Plaas

Open access · goldAbstract read
In one paragraph

Article in Arthritis research & therapy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it, 67 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Human osteoarthritis cartilage-derived stromal cells activate joint degeneration through TGF-beta lateral signaling.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. High molecular weight hyaluronan protects cartilage from degradation by inhibiting aggrecanase expression.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2018
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jun LiDepartment of Internal Medicine (Rheumatology), Rush University Medical Center, 1611 West Harrison Street Suite 510, Chicago, IL 60612, USA.
Daniel J Gorski
Wendy Anemaet
Jennifer Velasco
Jun Takeuchi
John D Sandy
Anna Plaas
Rush University Medical Center · USSeikagaku Corporation (Japan) · JP

Funding

Cartilage Degeneration and Repair By ADAMTSs and Hyaluronan Binding ProteinsR01AR057066 · NIAMS · RUSH UNIVERSITY MEDICAL CENTER · PI PLAAS, ANNA H. · 2011 to 2015
$1.7M
NIAMS NIH HHS R01 AR057066NIAMS NIH HHS R01AR057066
6 · The paper itself

Abstract

introductionThe mechanism by which intra-articular injection of hyaluronan (HA) ameliorates joint pathology is unknown. Animal studies have shown that HA can reduce synovial activation, periarticular fibrosis and cartilage erosion; however, its specific effects on the different cell types involved remain unclear. We have used the TTR (TGFbeta1 injection and Treadmill Running) model of murine osteoarthritis (OA), which exhibits many OA-like changes, including synovial activation, to examine in vivo tissue-specific effects of intra-articular HA.

methodsThe kinetics of clearance of fluorotagged HA from joints was examined with whole-body imaging. Naïve and treated knee joints were examined macroscopically for cartilage erosion, meniscal damage and fibrosis. Quantitative histopathology was done with Safranin O for cartilage and with Hematoxylin & Eosin for synovium. Gene expression in joint tissues for Acan, Col1a1, Col2a1, Col3a1, Col5a1, Col10a1, Adamts5 and Mmp13 was done by quantitative PCR. The abundance and distribution of aggrecan, collagen types I, II, III, V and X, ADAMTS5 and MMP13 were examined by immunohistochemistry.

resultsInjected HA showed a half-life of less than 2 h in the murine knee joint. At the tissue level, HA protected against neovascularization and fibrosis of the meniscus/synovium and maintained articular cartilage integrity in wild-type but not in Cd44 knockout mice. HA injection enhanced the expression of chondrogenic genes and proteins and blocked that of fibrogenic/degradative genes and proteins in cartilage/subchondral bone, whereas it blocked activation of both groups in meniscus/synovium. In all locations it reduced the expression/protein for Mmp13 and blocked Adamts5 expression but not its protein abundance in the synovial lining.

conclusionsThe injection of HA, 24 h after TGFbeta1 injection, inhibited the cascade of OA-like joint changes seen after treadmill use in the TTR model of OA. In terms of mechanism, tissue protection by HA injection was abrogated by Cd44 ablation, suggesting that interaction of the injected HA with CD44 is central to its protective effects on joint tissue remodeling and degeneration in OA progression.

Indexed as

ADAM ProteinsADAMTS5 ProteinAnimalsbetaIG-H3 ProteinCartilage, ArticularDisease Models, AnimalExtracellular Matrix ProteinsFibrosisHyaluronan ReceptorsHyaluronic AcidImmunohistochemistryInjections, Intra-ArterialMaleMatrix Metalloproteinase 13MiceMice, Inbred C57BLADAM ProteinsADAMTS5 ProteinAdamts5 protein, mousebetaIG-H3 ProteinExtracellular Matrix ProteinsHyaluronan ReceptorsHyaluronic AcidMatrix Metalloproteinase 13Transforming Growth Factor betaViscosupplements

Identifiers

PMID22721434
PMCPMC3446537
OpenAlexW2071988481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.